Heparan sulfate glycosaminoglycan lyase and uses thereof

Details for Australian Patent Application No. 2006311794 (hide)

Owner Momenta Pharmaceuticals, Inc.

Inventors Myette, James

Agent Davies Collison Cave

Pub. Number AU-B-2006311794

PCT Pub. Number WO2007/056218

Priority 11/265,908 03.11.05 US

Filing date 3 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 20 September 2012

International Classifications

C12N 9/88 Enzymes, e.g. ligases (6.) - Lyases (4.)

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/00 General processes for the preparation of peptides

C12P 19/00 Preparation of compounds containing saccharide radicals

C12P 19/04 Preparation of compounds containing saccharide radicals

C12Q 1/34 Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/056218 Priority application(s): WO2007/056218

20 September 2012 Application Accepted

  Published as AU-B-2006311794

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311795-[4-(6-halo-7-substituted-2,4-dioxo-1,4-di hydro2h-quinazolin-3-yl)-phenyl]-5-chloro-thio phen-2-yl-sulfonylureas and forms and methods related thereto

2006311786-Diphenylmethane derivatives as inhibitors of leukotriene biosynthesis